Pawel Wiczling
Cited by
Cited by
Prediction of peptide retention at different HPLC conditions from multiple linear regression models
T Ba̧czek, P Wiczling, M Marszałł, YV Heyden, R Kaliszan
Journal of Proteome Research 4 (2), 555-563, 2005
Simultaneous Determination of pKa and Lipophilicity by Gradient RP HPLC
P Wiczling, P Kawczak, A Nasal, R Kaliszan
Analytical chemistry 78 (1), 239-249, 2006
Determination of pKa by pH Gradient Reversed-Phase HPLC
P Wiczling, MJ Markuszewski, R Kaliszan
Analytical Chemistry 76 (11), 3069-3077, 2004
pH gradient reversed-phase HPLC
R Kaliszan, P Wiczling, MJ Markuszewski
Analytical chemistry 76 (3), 749-760, 2004
Overview of experimental and computational methods for the determination of the pKa values of 5-fluorouracil, cyclophosphamide, ifosfamide, imatinib and methotrexate
K Mioduszewska, J Dołżonek, D Wyrzykowski, Ł Kubik, P Wiczling, ...
TrAC Trends in Analytical Chemistry 97, 283-296, 2017
Gradient HPLC in the determination of drug lipophilicity and acidity
R Kaliszan, P Haber, T Baczek, D Siluk
Pure and Applied Chemistry 73 (9), 1465-1475, 2001
Reversed-phase TLC and HPLC retention data in correlation studies with in silico molecular descriptors and druglikeness properties of newly synthesized anticonvulsant …
N Perisic-Janjic, R Kaliszan, P Wiczling, N Milosevic, G Uscumlic, ...
Molecular Pharmaceutics 8 (2), 555-563, 2011
Population modeling of filgrastim PK‐PD in healthy adults following intravenous and subcutaneous administrations
W Krzyzanski, P Wiczling, P Lowe, E Pigeolet, M Fink, A Berghout, ...
The Journal of Clinical Pharmacology 50 (S9), 101S-112S, 2010
pH gradient high-performance liquid chromatography: theory and applications
R Kaliszan, P Wiczling, MJ Markuszewski
Journal of Chromatography A 1060 (1-2), 165-175, 2004
Potential pitfalls of propofol target controlled infusion delivery related to its pharmacokinetics and pharmacodynamics
A Bienert, P Wiczling, E Grzśkowiak, JB Cywiński, K Kusza
Pharmacological reports 64 (4), 782-795, 2012
pH/organic solvent double-gradient reversed-phase HPLC
P Wiczling, MJ Markuszewski, M Kaliszan, R Kaliszan
Analytical chemistry 77 (2), 449-458, 2005
Least absolute shrinkage and selection operator and dimensionality reduction techniques in quantitative structure retention relationship modeling of retention in hydrophilic …
E Daghir-Wojtkowiak, P Wiczling, S Bocian, Ł Kubik, P Kośliński, ...
Journal of Chromatography A 1403, 54-62, 2015
Pharmacokinetics and antibody responses to the CD3 antibody otelixizumab used in the treatment of type 1 diabetes
G Hale, P Rebello, I Al Bakir, E Bolam, P Wiczling, WJ Jusko, ...
The Journal of Clinical Pharmacology 50 (11), 1238-1248, 2010
Population pharmacokinetics of high-dose tigecycline in patients with sepsis or septic shock
A Borsuk-De Moor, E Rypulak, B Potręć, P Piwowarczyk, M Borys, ...
Antimicrobial agents and chemotherapy 62 (4), 10.1128/aac. 02273-17, 2018
Ultra-high performance liquid chromatographic determination of levofloxacin in human plasma and prostate tissue with use of experimental design optimization procedures
O Szerkus, J Jacyna, P Wiczling, A Gibas, M Sieczkowski, D Siluk, ...
Journal of Chromatography B 1029, 48-59, 2016
Pharmacokinetics and pharmacodynamics of a chimeric/humanized anti‐CD3 monoclonal antibody, otelixizumab (TRX4), in subjects with psoriasis and with type 1 diabetes mellitus
P Wiczling, M Rosenzweig, L Vaickus, WJ Jusko
The Journal of Clinical Pharmacology 50 (5), 494-506, 2010
The application of gradient reversed-phase high-performance liquid chromatography to the pKa and logkw determination of polyprotic analytes
P Wiczling, M Waszczuk-Jankowska, MJ Markuszewski, R Kaliszan
Journal of Chromatography A 1214 (1-2), 109-114, 2008
Verification of the exponential model of body temperature decrease after death in pigs
M Kaliszan, R Hauser, R Kaliszan, P Wiczling, J Buczyński, M Penkowski
Experimental Physiology 90 (5), 727-738, 2005
Pharmacokinetics and pharmacodynamics of propofol in patients undergoing abdominal aortic surgery
P Wiczling, A Bienert, P Sobczyński, R Hartmann-Sobczyńska, K Bieda, ...
Pharmacological Reports 64 (1), 113-122, 2012
The simultaneous determination of hydrophobicity and dissociation constant by liquid chromatography–mass spectrometry
P Wiczling, W Struck-Lewicka, D Siluk, MJ Markuszewski, R Kaliszan
Journal of Pharmaceutical and Biomedical Analysis 94, 180-187, 2014
The system can't perform the operation now. Try again later.
Articles 1–20